Dynavax Technologies Corporation (LON:0IDA)
15.49
-0.01 (-0.03%)
Feb 9, 2026, 5:37 PM GMT
Dynavax Technologies Revenue
Dynavax Technologies had revenue of $94.88M USD in the quarter ending September 30, 2025, with 17.67% growth. This brings the company's revenue in the last twelve months to $330.51M, up 26.73% year-over-year. In the year 2024, Dynavax Technologies had annual revenue of $277.25M with 19.36% growth.
Revenue (ttm)
$330.51M
Revenue Growth
+26.73%
P/S Ratio
n/a
Revenue / Employee
$816.08K
Employees
405
Market Cap
n/a
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 277.25M | 44.96M | 19.36% |
| Dec 31, 2023 | 232.28M | -490.40M | -67.86% |
| Dec 31, 2022 | 722.68M | 283.24M | 64.45% |
| Dec 31, 2021 | 439.44M | 392.89M | 844.00% |
| Dec 31, 2020 | 46.55M | 11.33M | 32.18% |
| Dec 31, 2019 | 35.22M | 27.02M | 329.60% |
| Dec 31, 2018 | 8.20M | 7.87M | 2,407.03% |
| Dec 31, 2017 | 327.00K | -10.72M | -97.04% |
| Dec 31, 2016 | 11.04M | 6.99M | 172.67% |
| Dec 31, 2015 | 4.05M | -6.98M | -63.29% |
| Dec 31, 2014 | 11.03M | -219.00K | -1.95% |
| Dec 31, 2013 | 11.25M | 1.54M | 15.82% |
| Dec 31, 2012 | 9.71M | -11.90M | -55.06% |
| Dec 31, 2011 | 21.61M | -2.34M | -9.75% |
| Dec 31, 2010 | 23.95M | -16.37M | -40.60% |
| Dec 31, 2009 | 40.32M | 3.22M | 8.69% |
| Dec 31, 2008 | 37.09M | 23.00M | 163.21% |
| Dec 31, 2007 | 14.09M | 9.25M | 190.76% |
| Dec 31, 2006 | 4.85M | -9.81M | -66.93% |
| Dec 31, 2005 | 14.66M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.24B |
| GSK plc | 32.67B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Spire Healthcare Group | 1.55B |
| CVS Group | 673.20M |
| Genus | 672.80M |
| HUTCHMED (China) | 439.54M |
Dynavax Technologies News
- 2 days ago - Sanofi (SNY) Finalizes Acquisition of Dynavax to Enhance Vaccine Portfolio - GuruFocus
- 8 days ago - Ciena Set to Join S&P 500; Arrowhead Pharmaceuticals to Join S&P MidCap 400; ADT and OneSpaWorld Holdings to Join S&P SmallCap 600 - PRNewsWire
- 13 days ago - Dynavax President and COO Sells 114,000 Shares on Sanofi Acquisition News - The Motley Fool
- 23 days ago - HARBOR CAPITAL ADVISORS, INC. Sells 5 Shares of Dynavax Technologies Corp (DVAX) - GuruFocus
- 4 weeks ago - Dynavax (DVAX) Sees Stock Rise Amid New Bidder Interest - GuruFocus
- 4 weeks ago - Dynavax gains on disclosure another bidder interested after deal announced - Seeking Alpha
- 5 weeks ago - $HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Dynavax Technologies Corporation (NASDAQ: DVAX) - PRNewsWire
- 6 weeks ago - Dynavax Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Dynavax Technologies Corporation - DVAX - PRNewsWire